After treatment with metformin in diabetes-susceptible B4 cells, the expression of nutrition excess-induced innate immunity/inflammasome molecules was ameliorated, including MDA5, NLRP3, caspase-1, and IL-1β. The gene discussed is NLRP3; the disease is diabetes mellitus.